Jul 2026· Cancer Research· Vol 86, pp. 4744-4754· 0 citations
Medicine
TL;DR
This review discusses tissue-specific programs, TME interactions, and systemic influences to illustrate how MYC-driven metabolic reprogramming creates context-dependent vulnerabilities and may uncover actionable targets and guide precision therapeutic strategies for MYC-driven cancers.
Abstract
The proto-oncogene MYC acts as a master regulator of diverse metabolic programs that fuel tumor initiation and progression, but the exact programs it activates depend heavily on context, tissue type, accompanying mutations, and the tumor microenvironment (TME). Furthermore, extrinsic influences, including diet and systemic metabolism, interact with MYC to reshape tumor and stromal cell metabolism, revealing a multifaceted metabolic landscape governed by MYC. This review focuses on MYC-driven in vivo metabolic addictions and discusses tissue-specific programs, TME interactions, and systemic influences to illustrate how MYC-driven metabolic reprogramming creates context-dependent vulnerabilities. These insights may uncover actionable targets and guide precision therapeutic strategies for MYC-driven cancers.
The multifaceted roles of MYC in different cancer types are highlighted and a comprehensive overview of current therapeutic strategies targeting MYC with a particular focus on epigenetic modifiers and metabolic vulnerabilities are provided.
Lourdes Sainero-Alcolado, Dilraj Lama, M. Alzrigat et al.· BioDrugs· 0 citations
This review systematically elaborates on the central role of "tumor-host" metabolic crosstalk in reshaping both the TME and the broader host macroenvironment, suggesting the need for multiscale metabolic interventions to improve cancer treatment efficacy.
Yi Zhang, Caixia Suo, Linchong Sun· Chinese Medical Journal· 0 citations
This chapter provides an integrated framework for understanding TAM biology across multiple regulatory dimensions, including ontogeny, plasticity, metabolism, epigenetic control, and spatial niche organization, and synthesizes current and emerging therapeutic strategies targeting TAM recruitment, survival, reprogrammin...
Atif Elnaggar, Abdelrahman Elnaggar· Advances in Cancer Research· 0 citations
Simple Summary Tumors develop within a complex microenvironment shaped by signals from cancer cells, host tissues, and the microbiome. We combined bacterial and archaeal profiling with host and tumor (xenograft) transcriptomes in orthotopic versus ectopic hepatoblastoma models to examine how tumor location relates to s...
Beate Obermüller, Sabine Obermüller, K. Wagner et al.· Cancers· 0 citations
The TEA domain transcription factors TEAD1 to TEAD4 integrate Hippo signaling with transcriptional programs that govern tissue homeostasis and cancer progression. Their activity is shaped by cofactor engagement, palmitoylation, chromatin organization and extracellular cues, creating therapeutic vulnerabilities that v...
Metastasis is the leading cause of cancer-related mortality, yet the mechanisms driving organ-specific colonization remain incompletely understood. Increasing evidence suggests that metastatic success depends on a "metabolic match" between disseminated tumor cells and the microenvironment of the target organ. In this m...
C. Álvarez-Álvarez, P. Altea-Manzano· Biochimica et biophysica act...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.
